Esther Rajavelu's Net Worth
$550 Thousand
Who is Esther Rajavelu?
Esther Rajavelu does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Fulcrum Therapeutics, Inc., and Spero Therapeutics, Inc..
SEC CIK
Esther Rajavelu's CIK is 0001903716
Past Insider Trading and Trends
2023 was Esther Rajavelu's most active year for acquiring shares with 2 total transactions. Esther Rajavelu's most active month to acquire stocks was the month of January. 2023 saw Esther Rajavelu paying a total of $0.00 for 460,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
See RemarksEsther Rajavelu owns 419,866 units of Common Stock which is worth $550,066.45. In the year 2023 Esther Rajavelu acquired a total of 419,866 shares in Spero Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.96% | 119.87K |
—
|
—
| 419.87K |
Feb 1
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||